ORI Healthcare Fund Invests in Pillar Biosciences

HONG KONG, CHINA—(Marketwired – May 11, 2016) – ORI Healthcare Fund L.P. (ORI Fund) announces the completion of US$18 million investment into Pillar Biosciences Inc., a Boston-based start-up specialized in next generation sequencing (“NGS”)-based clinical oncology testing in order to bring affordable precision medicine to cancer patients globally. Pillar Biosciences is prized with its patent-pending …

ORI Healthcare Fund Invests in Pillar Biosciences Read More »